Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature
Y Xu, J Qiao - Journal of healthcare engineering, 2022 - Wiley Online Library
The polycystic ovary syndrome (PCOS) is the disease featured by elevated levels of
androgens, ovulatory dysfunction, and morphological abnormalities. At reproductive stage of …
androgens, ovulatory dysfunction, and morphological abnormalities. At reproductive stage of …
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
HF Escobar-Morreale - Nature Reviews Endocrinology, 2018 - nature.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Study question What is the recommended assessment and management of those with
polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise …
polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise …
Using human genetics to understand the disease impacts of testosterone in men and women
Testosterone supplementation is commonly used for its effects on sexual function, bone
health and body composition, yet its effects on disease outcomes are unknown. To better …
health and body composition, yet its effects on disease outcomes are unknown. To better …
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
STUDY QUESTION What is the recommended assessment and management of women with
polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise …
polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise …
Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
S Abraham Gnanadass, Y Divakar Prabhu… - Archives of Gynecology …, 2021 - Springer
Background Polycystic ovarian syndrome (PCOS) is the most prevalent metabolic disorder
in reproductive-age women. It is indeed a multifactorial condition evidenced by ovarian …
in reproductive-age women. It is indeed a multifactorial condition evidenced by ovarian …
Polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
BACKGROUND Here we describe the consensus guideline methodology, summarise the
evidence-based recommendations we provided to the World Health Organisation (WHO) for …
evidence-based recommendations we provided to the World Health Organisation (WHO) for …
Polycystic ovary syndrome
CR McCartney, JC Marshall - New England Journal of Medicine, 2016 - Mass Medical Soc
Key Clinical Points Polycystic Ovary Syndrome The polycystic ovary syndrome is diagnosed
in women with at least two of the following otherwise unexplained abnormalities …
in women with at least two of the following otherwise unexplained abnormalities …
Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies
LH Zeng, S Rana, L Hussain, M Asif… - Frontiers in …, 2022 - frontiersin.org
Polycystic ovary syndrome (PCOS) is a very common, complex, and heterogeneous
endocrine disorder of women that involves a combination of environmental and genetic …
endocrine disorder of women that involves a combination of environmental and genetic …